DiabetesHealth – FDA lifts restrictions on patient access to Avandia

The drug – a rosiglitazone-based medicine that controls blood glucose by increased the body’s sensitivity to insulin, so cells and muscles are able to use more for energy, reducing levels in the blood – was off the market in Europe and restricted in the United States for several years due to studies showing the drug raised the risk of heart disease.

Read more

Posted in Drugs